Newly engineered psychedelic shows therapeutic promise without gastrointestinal distress
A recently developed psychedelic compound promotes brain plasticity and reduces anxiety in mice without triggering gastrointestinal distress. The findings provide a chemical blueprint for designing safer, more tolerable psychiatric treatments.
We haven't written up this one. PsyPost has the full story — the link below goes straight to it.